Business Context and Reporting Period
This Form 8-K is a current report filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on April 14, 2017. The filing addresses a specific corporate event regarding executive compensation and relocation.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is a specific one-time incentive payment.
- Relocation Incentive: $50,419.75
- Estimated Moving Costs: $20,000
- Total Estimated Cost: Approximately $70,419.75
Material Changes
The material change reported is the approval by the Compensation Committee of a relocation package for Steve Okland, the Commercial Vice President, U.S. and Canada. The incentive is effective April 14, 2017, to facilitate his move from Colorado to the Los Angeles area.
Guidance, Outlook, and Contingencies
The filing outlines specific repayment contingencies tied to Mr. Okland's employment status:
- If Mr. Okland voluntarily leaves or is terminated for cause within 12 months of receiving the incentive, he must repay the entire amount.
- If he leaves or is terminated for cause after the first anniversary but before the second anniversary, he must repay 50% of the incentive.
No forward-looking guidance, outlook, or other risk factors are disclosed in this specific filing.
Investor Verification Checklist
- Verify the total cash outflow impact of the $50,419.75 incentive plus actual moving costs on the company's operating expenses.
- Confirm the terms of the original Offer Letter (filed March 26, 2016) to ensure this package aligns with prior agreements.
- Monitor future filings for any repayment events if Mr. Okland's employment status changes within the 24-month window.